Cardiometabolic risks in PCOS: a review of the current state of knowledge
Authors:
- 15 December 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 14 (1) , 23-33
Abstract
Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 18% women of reproductive age. It is associated with a range of metabolic, reproductive, and psychological features. Current evidence indicates a role of PCOS in the development of metabolic and increased cardiovascular risk factors (CVRF) with implications for compromised cardiovascular end-point disease, which may have a considerable impact on health and health care costs. Areas covered: Existing studies examining long-term cardiometabolic health in PCOS are heterogeneous with inconsistent findings. In the current review, we aim to explore and critically review retrospective, prospective, meta-analysis and review articles relating to PCOS on cardiometabolic risk factors and clinical consequences to summarise the evidence, note evidence gaps, and suggest implications for future research. Expert commentary: While there is an established association between PCOS and metabolic health, implications on cardiac health are more uncertain with associations observed for CVFR and subclinical disease, yet limited and conflicting data on actual cardiovascular end-points. There is a lack of population-based long-term studies examining cardiometabolic morbidity and mortality in PCOS with a need for further research to progress towards a better understanding of the long-term cardiometabolic impacts in women with PCOS.Keywords
Funding Information
- Faculty of Medicine, Nursing and Health Sciences, Monash University
This publication has 78 references indexed in Scilit:
- Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocityJournal Of Hypertension, 2012
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertility and Sterility, 2012
- Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysisHuman Reproduction Update, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapiesExpert Opinion on Pharmacotherapy, 2010
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanBMC Medicine, 2010
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHuman Reproduction, 2009
- Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in HumansEndocrinology, 2009
- Polycystic ovary syndrome and its developmental originsReviews in Endocrine and Metabolic Disorders, 2007
- Coronary Heart Disease Risk Factors in Women With Polycystic Ovary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 1995